AnaptysBio Inc $ 28.70 2.72 (10.47%)
Volume:
544,541
Avg Vol (1m):
408,173
Market Cap $:
784.88 Mil
Enterprise Value $:
447.42 Mil
PE Ratio:
0.00
PB Ratio:
2.18
Financial Strength | 5/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 382.74 | ||
Debt-to-EBITDA | -0.01 | ||
Piotroski F-Score | 3 | ||
Altman Z-Score | 18.55 | ||
Beneish M-Score | 0.17 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Operating Margin % | -441.57 | ||
Net Margin % | -410.22 | ||
ROE % | -18.76 | ||
ROA % | -17.6 | ||
ROC (Joel Greenblatt) % | -4602.15 | ||
3-Year Revenue Growth Rate | -31.5 | ||
3-Year EBITDA Growth Rate | -162.5 | ||
3-Year EPS without NRI Growth Rate | -148.5 |
ANAB
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 2.18 | ||
PS Ratio | 43.48 | ||
EV-to-EBIT | -6.07 | ||
EV-to-EBITDA | -6.12 | ||
EV-to-Revenue | 24.86 | ||
Current Ratio | 14.13 | ||
Quick Ratio | 14.13 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -14.5 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 2.18 | ||
Earnings Yield (Greenblatt) % | -16.47 |